Wockhardt Ltd — Capital/Financing Update 2022

Aug 12, 2022

Ref. No.: WOCK/SEC/SE/2022-23/033

==> picture [178 x 49] intentionally omitted <==

12[th] August, 2022

BSE Limited National Stock Exchange of India Limited Corporate Relations Department Exchange Plaza P J Towers, Dalal Street Bandra Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 532300 NSE Symbol: WOCKPHARMA

Sub: Statement on Deviation or Variation of funds raised through Rights Issue for the quarter ended 30[th] June, 2022

Dear Sir/Madam,

Pursuant to Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, we hereby confirm that there has been no deviation in the utilisation of Issue proceeds from the objects as stated in the Letter of Offer for Rights Issue dated 4[th] March 2022.

The ‘Statement of deviation’, confirming Nil deviation, duly reviewed by the Audit Committee is attached herewith as ‘ Annexure A ’.

Kindly take the above information on record.

Thanking you,

for Wockhardt Limited

==> picture [121 x 55] intentionally omitted <==

Debashis Dey Company Secretary

Encl: A/a.

==> picture [112 x 49] intentionally omitted <==

==> picture [513 x 32] intentionally omitted <==

Annexure A

==> picture [178 x 49] intentionally omitted <==

Statement of Deviation / Variation in utilisation of funds raised

Name of the Company	Wockhardt Limited
Mode of Fund Raising	Rights Issue
Date of Raising Funds	28-03-2021
Amount Raised (in Rs. Crores)	748
Report filed for Quarter ended	30-06-2022
Monitoring Agency	Applicable
Monitoring Agency Name, if applicable	Care Ratings Limited
Is there a Deviation / Variation in use of funds raised	No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders	NA
If Yes, Date of shareholder Approval	NA
Explanation for the Deviation / Variation	NA
Comments of the Audit Committee after review	No Deviation
Comments of the auditors, if any	NA

Objects for which funds have been raised and where there has been a deviation, in the following table

Original Object	Modified Object, if any	Original Allocation (Rs. in crore)	Modified allocatio n, if any	Funds Utilised	Amount of Deviation/Variati on for the quarter according to applicable object	Remarks if any
Repayment, in full or part, of certain subordinated debt and certain outstanding borrowings (including interest) availed by the Company	No	590	Nil	590	Nil	In line with the objects in letter of offer
General corporate purposes	No	152	Nil	152.51	Nil	Savings in expenses related to rights issue utilised towards GCP as per the provision in letter of offer
Total Net Proceeds*		742		742.51

• Excluding estimated ‘Issue related expenses’.

==> picture [112 x 49] intentionally omitted <==

==> picture [513 x 32] intentionally omitted <==

==> picture [178 x 49] intentionally omitted <==

Deviation or variation could mean:

(a) Deviation in the objects or purposes for which the funds have been raised or

(b) Deviation in the amount of funds actually utilized as against what was originally disclosed or

(c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc

==> picture [121 x 56] intentionally omitted <==

Name of the Signatory : Debashis Dey Designation : Company Secretary & Compliance Officer

==> picture [112 x 49] intentionally omitted <==

==> picture [513 x 32] intentionally omitted <==